Caspase-3 (RM250), RMab

Summary and Explanation

Dysregulated apoptosis is a typical characteristic of human cancer. Abnormal Caspase-3 antibody expression has been directly associated with acute Myelogenous Leukemia, where Caspase-3 overexpression has been detected. On the contrary, decreased expression of Caspase-3 has been found in Prostate Cancer. Another study has found a significant association between high Caspase-3 levels and increased death rates in Breast Cancer using IHC, highlighting the prognostic potential of Caspase-3. In another study, IHC analysis of Gastric, Ovarian, Cervical, and Colorectal Cancer demonstrated that patients with high expression of cleaved Caspase-3 had a significantly shorter overall survival time compared with those with low cleaved Caspase-3 expression. Additionally, a link between Caspase-3 antibody expression and tumor stage and lymph node metastasis was found in Gastric and Ovarian cancer. Caspase-3 is the predominant caspase involved in amyloid-β precursor protein (APP) cleavage, consistent with its marked elevation in dying neurons of Alzheimer’s disease brains and colocalization of its APP cleavage product with Aβ in senile plaques. Caspases thus appear to play a dual role in proteolytic processing of APP and the resulting propensity for Aβ peptide formation, as well as in the ultimate apoptotic death of neurons in Alzheimer’s disease.

---

Synonyms: caspase-3, anti-caspase-3, caspase3, caspase 3, anti-caspase, casepase, anti-casepase, casepase-3, casepase 3, anti-casepase-3, cystein-aspartic acid protease encoded, casp3, anti-casp3, casp-3, anti-casp-3